Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03814382 · ClinicalTrials.gov registry record · NA
Acupuncture to Reduce Anxiety in Alzheimer's Disease (AD) and AD Related Dementias
A NA study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03814382: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT03814382 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03814382, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the influence of acupuncture on heart rate variability, skin conductance (sweating), and rated behavioral expression of agitation, irritability, and anxiety and mood in qualifying adults with a diagnosis of cognitively unimpaired, or probable Alzheimer's Disease, Frontotemporal Dementia or Dementia with Lewy Bodies. Study subjects will all receive one real acupuncture treatment; mood scales will be assessed before and after. Massachusetts General Hospital is paying for this research to be done.
Interventions
- DEVICE Acupuncture needle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-03-11 |
| Est. Completion | 2020-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03814382
The ClinicalTrials.gov registry entry for NCT03814382 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acupuncture needle is the first listed.
NCT03814382 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03814382 about?
NCT03814382 is a clinical study titled "Acupuncture to Reduce Anxiety in Alzheimer's Disease (AD) and AD Related Dementias". The purpose of this study is to investigate the influence of acupuncture on heart rate variability, skin conductance (sweating), and rated behavioral expression of agitation, irritability, and anxiety and mood in qualifying adults with a diagnosis of cognitively unimpaired, or probable Alzheimer's D...
What is the current status of trial NCT03814382?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2019-03-11. Estimated completion is 2020-02-01.
What interventions are being tested in trial NCT03814382?
The interventions under investigation include: Acupuncture needle (DEVICE).
Who is sponsoring clinical trial NCT03814382?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.